1. Home
  2. INFU vs GNFT Comparison

INFU vs GNFT Comparison

Compare INFU & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • GNFT
  • Stock Information
  • Founded
  • INFU 2005
  • GNFT 1999
  • Country
  • INFU United States
  • GNFT France
  • Employees
  • INFU N/A
  • GNFT N/A
  • Industry
  • INFU Medical/Dental Instruments
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INFU Health Care
  • GNFT Health Care
  • Exchange
  • INFU Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • INFU 189.2M
  • GNFT 172.2M
  • IPO Year
  • INFU N/A
  • GNFT 2019
  • Fundamental
  • Price
  • INFU $8.04
  • GNFT $3.45
  • Analyst Decision
  • INFU
  • GNFT Strong Buy
  • Analyst Count
  • INFU 0
  • GNFT 1
  • Target Price
  • INFU N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • INFU 66.6K
  • GNFT 6.9K
  • Earning Date
  • INFU 03-13-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • INFU N/A
  • GNFT N/A
  • EPS Growth
  • INFU 60.96
  • GNFT N/A
  • EPS
  • INFU 0.07
  • GNFT 0.47
  • Revenue
  • INFU $132,783,999.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • INFU $10.23
  • GNFT $145.20
  • Revenue Next Year
  • INFU $8.80
  • GNFT N/A
  • P/E Ratio
  • INFU $116.00
  • GNFT $7.17
  • Revenue Growth
  • INFU 8.17
  • GNFT 175.45
  • 52 Week Low
  • INFU $5.74
  • GNFT $3.33
  • 52 Week High
  • INFU $10.03
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • INFU 46.89
  • GNFT 29.90
  • Support Level
  • INFU $7.42
  • GNFT $3.35
  • Resistance Level
  • INFU $8.42
  • GNFT $3.57
  • Average True Range (ATR)
  • INFU 0.35
  • GNFT 0.12
  • MACD
  • INFU -0.02
  • GNFT 0.00
  • Stochastic Oscillator
  • INFU 44.93
  • GNFT 17.27

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: